Novanta Inc is primarily active in the industries of precision motion control, photonics, and medical technologies.

The main competitors of Novanta Inc in the market are Danaher Corporation, Coherent Inc, and IPG Photonics.

Novanta Inc is a leading global supplier of precision photonic and motion control components and subsystems. Founded in 1968 as GSI Group, the company later rebranded as Novanta in 2016 to better reflect its strategic focus. Novanta Inc specializes in developing innovative products for medical and advanced industrial applications, catering to customers in various industries such as healthcare, life sciences, and industrial automation. With a rich history spanning over five decades, Novanta Inc has established a solid reputation for delivering cutting-edge solutions that enable its customers to achieve their goals efficiently and effectively.

Novanta Inc has achieved numerous significant milestones since its establishment. The company, recognized as a global leader in precision photonics solutions, has made remarkable progress. Novanta Inc successfully expanded its presence across various industries, such as medical and advanced industrial markets. They have consistently delivered innovative technologies, driving advancements in areas like medical diagnostics, laser processing, and 3D printing. Novanta Inc has also established strategic partnerships and acquired key businesses to enhance its product portfolio and market position. Their commitment to innovation, customer-centric approach, and continuous growth have contributed to Novanta Inc's notable achievements in the industry.

Novanta Inc is primarily present in various countries and regions. The company has a global presence, with key markets in North America, Europe, and Asia. This multinational corporation operates across multiple continents, serving customers from diverse industries in these regions. Novanta Inc's extensive geographical reach allows it to capitalize on opportunities and effectively meet the demands of customers worldwide.

Novanta Inc represents values of innovation, excellence, and collaboration. With a strong corporate philosophy focused on driving technological advancements, Novanta delivers cutting-edge solutions across its diverse product portfolio. The company consistently strives for superior customer satisfaction by providing high-quality, precision technologies to its global customer base. Novanta fosters a culture of innovation and teamwork, fostering collaboration both internally and with strategic partners. As an industry leader, Novanta Inc is dedicated to pushing boundaries and enabling advancements in industries such as medical and industrial markets.

Analysts currently set an average price target of 158,61 USD for the Novanta stock (median: 161,67 USD), implying +11,3 % versus the latest price. The consensus is based on 10 analyst ratings.

Novanta Analyytikkojen kursstavoitteet 2026

10 analysts currently rate the Novanta stock: 7 recommend buying, 3 holding and 0 selling. For 2026, analysts expect Novanta to generate revenue of 1,05 Mrd. USD and earnings per share of 3,41 USD.

Novanta Analyytikkojen kursstavoitteet 2026

Converted at the current exchange rate, the Novanta share trades at 123,54 EUR (142,55 USD).

The Novanta share (NOVT) is listed on 4 stock exchanges, including: NASDAQ (NOVT), Frankfurt (1GSN.F), London (0VAG.L), London (0VAG.L).

Novanta Inc is a leading provider of precision solutions for advanced technology and scientific applications. The company offers a comprehensive product portfolio and a global network of sales and service centers to meet the needs of its customers. Novanta's business model is based on interconnected divisions, including Photonics, Precision Motion, and Automated Assembly Solutions, which provide optical technologies, precision mechanics and controls, and automation technologies respectively. The company also offers other specialized products and solutions, such as ultrasound and electromedical instruments. Novanta primarily serves OEMs in the medical technology, industrial automation, and scientific instrumentation sectors, and focuses on innovation and research and development to meet evolving customer demands. In summary, Novanta is a leading provider of precision solutions across various industries, with a diversified business model emphasizing innovation and customer satisfaction.

odotettu liikevaihto Novanta on 1,05 Mrd. USD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.

odotettu voitto Novanta on 131,76 M USD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.

Novanta:n hinta-voitto-suhde (P/E) on tällä hetkellä 41,85. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Novanta-osakkeen arvostusta.

Novanta:n hinta-myynti-suhde (P/S) on tällä hetkellä 5,23. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Novanta-osakkeen arvostuskennuslukuna.

Novanta:n Eulpool-laatuscore on 5/10.

Novanta:n ISIN on CA67000B1040. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.

Novanta:n WKN on A2AJW7. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.

Novanta:n ticker on NOVT. Tämä pörssinoteeraus käytetään Novanta-osakkeiden kauppaan pörssissä.

Novanta maksoi osinkoa joka vuosi viimeisten 0 vuoden aikana.

Novanta kuuluu sektoriin 'Informaatioteknologia'.

Novanta:n osingot jaetaan valuutassa USD.